North America Injectable Drug Delivery Market (2018 to 2023) – Segmented by Type, Application, and Geography – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “North America Injectable Drug Delivery Market – Segmented by Type, Application, and Geography – Growth, Trends, and Forecast (2018 – 2023)” report has been added to ResearchAndMarkets.com’s offering.

The North American injectable drug delivery technology market is expected to register a CAGR of over 13% during the forecast period of 2018-2023. Injectable drug delivery technologies allow the transport of drugs formulated in liquid form and facilitate the rapid transport of the drug into the body. It also helps in administering drugs in unconscious and comatose patients. These delivery systems are widely accepted due to their advantage of a faster onset of action with high efficacy. Also, in recent years, this market has grown due to the increased prevalence of cancer and diabetes.

Some of the most common chronic diseases include heart disease, stroke, type 2 diabetes, obesity, cancer, and arthritis. According to the Center for Disease Control and Prevention (CDC), in the United States, seven of the top 10 causes of death in 2014 were chronic diseases. Cancer and heart disease together accounted for an approximate of 46% of all deaths. It was also reported that about half of the adults in the United States had one or more chronic conditions and one if four had more than two chronic conditions. Moreover, these numbers are expected to increase in the next 10 years. Since the adoption rate of injectable drug delivery devices is high among the population suffering from diseases like diabetes and heart-related disorders, the increasing prevalence of chronic diseases is expected to contribute to the growth of injectable drug delivery technology market in the forecast period.

Injuries and infections due to needles are acting as a major restraint for the global injectable drug delivery technology market. According to the Occupational Safety & Health Administration (OSHA) estimates, 5.6 million workers in the healthcare industry are at a risk of needle injuries. Moreover, there has been an increment in the infections caused by needles over the past few years. Therefore with the increasing injuries and the infections caused by needles, there is reluctance among people to use injections, hampering the growth of the injectable drug delivery technology market.

Companies Mentioned

• Antares Pharmaceutical Inc.
• Baxter International
• Becton Dickinson and Company
• Elcam Medical
• Eli Lilly and Company
• Unilife Corporation
• West Pharmaceutical Services Inc
  

Reasons to Purchase the Report

• Follow the current and future North America injectable drug delivery technology market in the developed and emerging markets.
• Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
• Identify the segment that is expected to dominate the market.
• Identify the regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support along with the Market Estimate sheet (in Excel).

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

5.1 Current Market Scenario

5.2 Porter’s Five Forces Analysis

5.2.1 Bargaining Power of Suppliers

5.2.2 Bargaining Power of Consumers

5.2.3 Threat of New Entrants

5.2.4 Threat of Substitute Products and Services

5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

6.1 Drivers

6.1.1 Increasing Prevalence of Chronic Diseases

6.1.2 Benefits and Convenience with the Use of Injections

6.2 Restraints

6.2.1 Injuries and Infections Caused by Needles

6.2.2 Growing Use of Alternative Delivery Methods

6.2.3 Safety Concerns

6.3 Opportunities

6.4 Key Challenges

7. Market Segmentation

7.1 By Type

7.1.1 Devices

7.1.1.1 Self-injection Devices

7.1.1.2 Conventional Injection Devices

7.1.2 Formulation

7.1.2.1 Conventional Drug Delivery

7.1.2.2 Novel Drug Delivery

7.1.2.3 Others

7.2 By Application

7.2.1 Cardiovascular Disease

7.2.2 Diabetes

7.2.3 Regenerative Medicine

7.2.4 Oncology

7.2.5 Autoimmune Disorders

7.2.6 Hepatitis B

7.2.7 Others

7.3 By Geography

7.3.1 North America

7.3.1.1 United states

7.3.1.2 Canada

7.3.1.3 Mexico

8. Competitive Landscape

8.1 Mergers & Acquisition Analysis

8.2 Agreements, Collaborations, and Partnerships

8.3 New Products Launches

9. Key Players

10. Future of the Market

11. Disclaimer

For more information about this report visit https://www.researchandmarkets.com/r/d1304c

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900